High-density lipoprotein increases the uptake of oxidized low density lipoprotein via PPARγ/CD36 pathway in inflammatory adipocytes

International Journal of Biological Sciences

Volumn 11, Issue 3, 2015, Pages 256-265

  Zhong, Qiaoqing ^a,b,c   Zhao, Shuiping ^c   Yu, Bilian ^c   Wang, Xing ^d   Matyal, Robina ^e   Li, Yunping ^e   Jiang, Zhisheng ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b THE FIRST PEOPLE S HOSPITAL OF CHENZHOU   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Atherosclerosis; Inflammation; Lipopolysaccharide; Lipoprotein

Indexed keywords

ADIPOCYTOKINE; CD36 ANTIGEN; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

3T3 CELL LINE; ADIPOCYTE; ANIMAL; METABOLISM; MOUSE; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

3T3 CELLS; ADIPOCYTES; ADIPOKINES; ANIMALS; ANTIGENS, CD36; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; METABOLIC NETWORKS AND PATHWAYS; MICE; OXIDATION-REDUCTION; PPAR GAMMA;

EID: 84922347093     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.10258     Document Type: Article

References (32)

1. Samad F, Ruf W. Inflammation, obesity, and thrombosis. Blood. 2013; 122: 3415-22.
2. Lee J. Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes. Archives of pharmacal research. 2013; 36: 208-22.
3. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. The Journal of clinical investigation. 2003; 112: 1785-8.
4. Bondia-Pons I, Ryan L, Martinez JA. Oxidative stress and inflammation interactions in human obesity. Journal of physiology and biochemistry. 2012; 68: 701-11.
5. Mottillo EP, Bloch AE, Leff T, Granneman JG. Lipolytic products activate peroxisome proliferator-activated receptor (PPAR) alpha and delta in brown adipocytes to match fatty acid oxidation with supply. The Journal of biological chemistry. 2012; 287: 25038-48.
6. Townsend KL, An D, Lynes MD, Huang TL, Zhang H, Goodyear LJ, et al. Increased mitochondrial activity in BMP7-treated brown adipocytes, due to increased CPT1-and CD36-mediated fatty acid uptake. Antioxidants & redox signaling. 2013; 19: 243-57.
7. Kawahara A, Haraguchi N, Tsuchiya H, Ikeda Y, Hama S, Kogure K. Peroxisome proliferator-activated receptor gamma (PPARgamma)-independent specific cytotoxicity against immature adipocytes induced by PPARgamma antagonist T0070907. Biological & pharmaceutical bulletin. 2013; 36: 1428-34.
8. Kliewer SA, Lehmann JM, Willson TM. Orphan nuclear receptors: Shifting endocrinology into reverse. Science. 1999; 284: 757-60.
9. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Molecular cell. 1999; 4: 611-7.
10. Sundaresan S, Shahid R, Riehl TE, Chandra R, Nassir F, Stenson WF, et al. CD36-dependent signaling mediates fatty acid-induced gut release of secretin and cholecystokinin. FASEB journal : Official publication of the Federation of American Societies for Experimental Biology. 2013; 27: 1191-202.
11. Takai M, Tsuzuki S, Matsuno Y, Kozai Y, Eguchi A, Matsumura S, et al. Assessment of key amino-acid residues of CD36 in specific binding interaction with an oxidized low-density lipoprotein. Bioscience, biotechnology, and biochemistry. 2013; 77: 1134-7.
12. Zhao SP, Wu ZH, Hong SC, Ye HJ, Wu J. Effect of atorvastatin on SR-BI expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits. Clinica chimica acta; international journal of clinical chemistry. 2006; 365: 119-24.
13. Zhao SP, Wu J, Zhang DQ, Ye HJ, Liu L, Li JQ. Fenofibrate enhances CD36 mediated endocytic uptake and degradation of oxidized low density lipoprotein in adipocytes from hypercholesterolemia rabbit. Atherosclerosis. 2004; 177: 255-62.
14. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. The Journal of biological chemistry. 1993; 268: 11811-6.
15. Han S, Sidell N. Peroxisome-proliferator-activated-receptor gamma (PPARgamma) independent induction of CD36 in THP-1 monocytes by retinoic acid. Immunology. 2002; 106: 53-9.
16. Zhao SP, Yang J, Li J, Dong SZ, Wu ZH. Effect of niacin on LXRalpha and PPARgamma expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits. International journal of cardiology. 2008; 124: 172-8.
17. Salacinski PR, McLean C, Sykes JE, Clement-Jones VV, Lowry PJ. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). Analytical biochemistry. 1981; 117: 136-46.
18. Ohgami N, Nagai R, Ikemoto M, Arai H, Kuniyasu A, Horiuchi S, et al. Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products. The Journal of biological chemistry. 2001; 276: 3195-202.
19. Sakai M, Kobori S, Matsumura T, Biwa T, Sato Y, Takemura T, et al. HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein. Atherosclerosis. 1997; 133: 51-9.
20. Barter P. Effects of inflammation on high-density lipoproteins. Arteriosclerosis, thrombosis, and vascular biology. 2002; 22: 1062-3.
21. Charriere G, Cousin B, Arnaud E, Andre M, Bacou F, Penicaud L, et al. Preadipocyte conversion to macrophage. Evidence of plasticity. The Journal of biological chemistry. 2003; 278: 9850-5.
22. Ryan VH, German AJ, Wood IS, Hunter L, Morris P, Trayhurn P. Adipokine expression and secretion by canine adipocytes: Stimulation of inflammatory adipokine production by LPS and TNFalpha. Pflugers Archiv : European journal of physiology. 2010; 460: 603-16.
23. Hoch M, Eberle AN, Peterli R, Peters T, Seboek D, Keller U, et al. LPS induces interleukin-6 and interleukin-8 but not tumor necrosis factor-alpha in human adipocytes. Cytokine. 2008; 41: 29-37.
24. Han J, Hajjar DP, Zhou X, Gotto AM Jr., Nicholson AC. Regulation of peroxisome proliferator-activated receptor-gamma-mediated gene expression. A new mechanism of action for high density lipoprotein. The Journal of biological chemistry. 2002; 277: 23582-6.
25. Barsig J, Kusters S, Vogt K, Volk HD, Tiegs G, Wendel A. Lipopolysaccharide-induced interleukin-10 in mice: Role of endogenous tumor necrosis factor-alpha. European journal of immunology. 1995; 25: 2888-93.
26. Torres MB, Vega VL, Bedri M, Saad D, Trentzsch H, Reeves RH, et al. IL-10 plasma levels are elevated after LPS injection in splenectomized A/J mice. The Journal of surgical research. 2005; 129: 101-6.
27. Berg DJ, Kuhn R, Rajewsky K, Muller W, Menon S, Davidson N, et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. The Journal of clinical investigation. 1995; 96: 2339-47.
28. Ma L, Dong F, Zaid M, Kumar A, Zha X. ABCA1 protein enhances Toll-like receptor 4 (TLR4)-stimulated interleukin-10 (IL-10) secretion through protein kinase A (PKA) activation. The Journal of biological chemistry. 2012; 287: 40502-12.
29. Zhao SP, Zhang DQ. Atorvastatin enhances cellular uptake of oxidized LDL in adipocytes from hypercholesterolemic rabbits. Clinica chimica acta; international journal of clinical chemistry. 2004; 339: 189-94.
30. Kuniyasu A, Hayashi S, Nakayama H. Adipocytes recognize and degrade oxidized low density lipoprotein through CD36. Biochemical and biophysical research communications. 2002; 295: 319-23
31. D'Archivio M, Scazzocchio B, Filesi C, Vari R, Maggiorella MT, Sernicola L, et al. Oxidised LDL up-regulate CD36 expression by the Nrf2 pathway in 3T3-L1 preadipocytes. FEBS letters. 2008; 582: 2291-8.
32. Wu ZH, Zhao SP. Niacin promotes cholesterol efflux through stimulation of the PPARgamma-LXRalpha-ABCA1 pathway in 3T3-L1 adipocytes. Pharmacology. 2009; 84: 282-7.